TRUXIMA

Serial Number 79168237
Registration 4962045
706

Registration Progress

Application Filed
Feb 27, 2015
Under Examination
Approved for Publication
Mar 8, 2016
Published for Opposition
Mar 8, 2016
Registered
May 24, 2016

Attorney Assistance

Section 71 Renewal Due (Principal Register 66a) (Based on registration date 20160524)
Due: May 24, 2026 114 days

Trademark Image

TRUXIMA

Basic Information

Serial Number
79168237
Registration Number
4962045
Filing Date
February 27, 2015
Registration Date
May 24, 2016
Published for Opposition
March 8, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
706
Status Date
Oct 14, 2022
Registration
Registered
Classes
005

Rights Holder

CELLTRION, INC.

03
Address
23, Academy-ro,
Yeonsu-gu
Incheon 406-840
KR

Ownership History

CELLTRION, INC.

Original Applicant
03
KR

CELLTRION, INC.

Owner at Publication
03
KR

CELLTRION, INC.

Original Registrant
03
Incheon KR

Legal Representation

Attorney
Kisuk Lee

USPTO Deadlines

Next Deadline
114 days remaining
Section 71 Renewal Due (Principal Register 66a) (Based on registration date 20160524)
Due Date
May 24, 2026
Grace Period Ends
November 24, 2026

Application History

37 events
Date Code Type Description Documents
May 24, 2025 REM4 E COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Loading...
Feb 6, 2025 RNWL P INTERNATIONAL REGISTRATION RENEWED Loading...
Oct 14, 2022 NA71 E NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Loading...
Oct 14, 2022 71AG O REGISTERED-SEC.71 ACCEPTED Loading...
Oct 12, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 18, 2022 ES71 I TEAS SECTION 71 RECEIVED Loading...
Nov 5, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
May 24, 2021 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Feb 12, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Sep 16, 2016 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Aug 26, 2016 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Aug 26, 2016 FIMP P FINAL DISPOSITION PROCESSED Loading...
Aug 24, 2016 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
May 24, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 8, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 8, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 4, 2016 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Feb 17, 2016 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 17, 2016 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 17, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 1, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 27, 2016 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 27, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 27, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 21, 2016 ALIE A ASSIGNED TO LIE Loading...
Jan 8, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 29, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 29, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 1, 2015 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 11, 2015 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 10, 2015 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jul 10, 2015 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 9, 2015 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jul 8, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 7, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 7, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 2, 2015 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammations; pharmaceutical preparations for the treatment of transplant rejection; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases

Classification

International Classes
005